JPRN-UMIN000008148已完成1 期
Phase I study of weekly low dose Paclitaxel for pancreato-biliary cancers after failure of gemcitabine and 5-FU - Palliative chemotherapy with paclitaxel for pancreato-biliary cancers
Kanazawa University Hospital Hepato-Biliary-Pancreatic Surgery0 个研究点目标入组 16 人开始时间: 2012年6月14日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
BTC: PR 3, SD 2, PD 1 PDAC: SD 4, PD 6
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with a history of anti-cancer agent taxane administration.
研究者
相似试验
已完成
2 期
Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck CancerHead and Neck CancerNCT01024101Bristol-Myers Squibb36
已完成
2 期
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)Non-Small Cell Lung CancerNCT01024062Bristol-Myers Squibb60
已完成
2 期
Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast CancerBreast CancerNCT01023204Bristol-Myers Squibb68
已完成
2 期
Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck CancerHead and Neck CancerNCT00855764Bristol-Myers Squibb36
Unknown
1 期
Dose-finding Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and Bulky IIA Cervical CancerCervical CancerNCT00823186Chang Gung Memorial Hospital21